Erbitux Pregnancy


  • Infusion (IV)
  • Head and neck cancer
  • Locally or regionally advanced squamous cell
  • in combination with radiation therapy. Head and neck cancer
  • Metastatic or recurrent squamous cell
  • as monotherapy
  • in patients who failed prior platinum-based therapy. Head and neck cancer
Back to: Full Site Navigation

Is Erbitux (Cetuximab) safe during pregnancy or nursing?

The FDA category for this medication is C. It is advised that you: Weigh risks vs. benefits

Erbitux (Cetuximab) pregnancy info from our pharmacists

  • Upsides
  • No info available
  • Downsides
  • No info available
  • Tips
  • No info available
  • Risks
  • No info available
Source: FDA package insert